MRCEM Notes

Paracetamol

On this page
Paracetamol, also known as acetaminophen, is a non-opioid analgesic with anti-pyretic properties but has no demonstrable anti-inflammatory activity. Paracetamol has very few side effects and is generally considered sage in pregnancy and breastfeeding. Paracetamol in overdose can result in significant hepatic injury.

Paracetamol metabolism & poisoning

The liver normally metabolises paracetamol by conjugation with glucuronic acid and sulphuric acid. A small amount of paracetamol is metabolised by cytochrome p450 oxidases into the toxic metabolite N-acetyl-p-benzoquinone imine or NAPQI. Under normal circumstances NAPQI will be conjugated by glutathione into the non-toxic mercapturic acid.

During an overdose these conjugation systems become saturated leading to:
  • More paracetamol being metabolised by cytochrome p450 oxidases and increased production of NAPQI
  • Increased NAPQI exhausts glutathione stores
  • NAPQI forms covalent bonds with cell proteins denaturing them and causing cell death in hepatocytes and renal tubules

N-acetylcysteine (NAC) is used in the management of paracetamol overdose as it is a precursor of glutathione which can increase hepatic glutathione production and conjugate excess NAPQI.

Paracetamol poisoning key points

  • Paracetamol poisoning is a common presentation to ED.
  • Levels should be taken at 4 hours post ingestion. Before this serum levels are not helpful.
  • Patients are at increased risk of hepatic damage if they are on enzyme inducing drugs.
  • Liver damage is maximal at 3-4 days after ingestion.
  • Significant acute overdose is considered as >75mg/kg all taken within 1 hour and >8 hrs since ingestion OR therapeutic excess, repeated (staggered) overdose taken over 1 hour or more.
  • Activated Charcoal (50g) treatment is advised if patient has taken >150mg/kg paracetamol within the last hour
  • Treatment with N-acetylcysteine infusion is typically based on the plasma paracetamol levels and if these fall above or below the treatment line (see below)

  • The nomogram is unreliable if timing of OD is uncertain. If in doubt treat.
  • For pregnant women the NPIS advises that the toxic dose be calculated using the patients pre-pregnancy weight and the antidote dose be calculated using the patients’ actual pregnant weight.
  • NPIS advises that for any adult patient weighing more than 110kg the toxic dose in mg/kg sh
Click on image to enlarge

Patients at risk of liver damage, and therefore requiring acetylcysteine, can be identified from a single measurement of the plasma-paracetamol concentration related to the time from ingestion, provided this time interval is not less than 4 hours; earlier samples cannot be interpreted.
Full-size image